Bruker (BRKR) Tops Q1 EPS by 9c; raises guidance

Bruker (NASDAQ: BRKR) reported Q1 EPS of $0.64, $0.09 better than the analyst estimate of $0.55. Revenue for the quarter came in at $685.3 million versus the consensus estimate of $639.76 million.

GUIDANCE:

Bruker sees FY2023 EPS of $2.55-$2.60, versus the consensus of $2.56. Bruker sees FY2023 revenue of $2.83-2.88 billion, versus the consensus of $2.82 billion.

For earnings history and earnings-related data on Bruker (BRKR) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c